Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an

Launched by XI'AN NO.3 HOSPITAL · Jun 17, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment system for patients who have experienced an acute ischemic stroke, which is when blood flow to the brain is blocked. The goal is to see how well this standardized treatment system works in real-life situations in Xi'an, China. Researchers will look at various outcomes after 90 days, including how well patients recover, the rate of complications like bleeding in the brain, and if patients have any repeat strokes.

To participate, you need to be at least 18 years old and have been diagnosed with acute ischemic stroke within 24 hours of the onset of symptoms. However, those with certain conditions, like severe liver or kidney problems, or those who refuse specific treatments, will not be eligible. Participants can expect to have their health closely monitored and provide information to help researchers understand the effectiveness of this treatment system. This trial is currently recruiting participants, and it's important to know that if you choose to join, you'll need to give your informed consent.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years old;
• • Consistent with the diagnosis of acute ischemic stroke;
• • 24 hours from onset to enrollment;
• • Informed consent
• Exclusion Criteria:
• • Patients who refuse to receive intravenous thrombolysis or intravascular intervention (including intravascular mechanical thrombolysis and arterial thrombolysis);
• • Stroke patients caused by brain tumor, brain trauma and blood diseases;
• • Those with a history of stroke and sequelae affecting the outcome assessment, namely, mRS 2 points before the onset of this stroke;
• • Combined with claudication osteoarthritis rheumatoid arthritis gout arthritis and other limb dysfunction and affect the neurological function examination;
• • Patients with severe hepatic and renal insufficiency (Note: Hepatic insufficiency refers to ALT or AST values greater than 2 times the upper normal limit; Renal insufficiency refers to blood creatinine value greater than 2 times the normal upper limit);
• • Suffering from other serious life-threatening diseases with an expected survival time of less than 3 months;
• • Other diseases that limit neurological function evaluation or affect patient follow-up;
• • A woman planning to be pregnant or breastfeeding;
• • Currently participating in other clinical trials;
• • Refuse to participate in the registration of investigators